SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Schnereger who wrote (244)7/19/1996 7:59:00 PM
From: Michael Yang   of 4342
 
Jim,

I already saw the bizweek article, which is out, can be found in every library.

Dr. Cohen would be on the conference call as well. So I think he would have gotten the credit. The objection came, in my opinion, from the journal that publishes the original findings of Dr. Cohen. Some journals have strict policy regarding to "leak" of the data prior to the date of publication. As to where the paper gets to be published, it is really hard to make prediction. But if the authors showed that the mos kinase is involved in HIV-induced cell deaths, this would be a Science paper.

I suspect that some money are getting out of stocks that are considered "speculative", because of this market. I wish that I picked more shares when it was 3. BTW, now I like the way Richard was trading the PRLN, in and out, and maximizing the profit.

Michael
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News